An update on type 2 diabetes, vascular dementia and Alzheimer's disease.
about
Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalMetabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and TreatmentType 2 diabetes and cognitive impairment: contributions from neuroimagingDeconstructing racial differences: the effects of quality of education and cerebrovascular risk factorsRole of anti-diabetic drugs as therapeutic agents in Alzheimer's diseaseComorbidity and dementia: A nationwide survey in Taiwan.Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: the PREDIMED-NAVARRA trial.Diabetes and the brain: issues and unmet needs.Brain lipidomes of subcortical ischemic vascular dementia and mixed dementiaSpontaneous brain activity in type 2 diabetics revealed by amplitude of low-frequency fluctuations and its association with diabetic vascular disease: a resting-state FMRI study.Brain structural changes and their correlation with vascular disease in type 2 diabetes mellitus patients: a voxel-based morphometric studyMidlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study.Glycemia and cognitive function in metabolic syndrome and coronary heart disease.Non-invasive screening for Alzheimer's disease by sensing salivary sugar using Drosophila cells expressing gustatory receptor (Gr5a) immobilized on an extended gate ion-sensitive field-effect transistor (EG-ISFET) biosensor.Severe diabetic retinal disease and dementia risk in type 2 diabetes.Preliminary results of highly localized plantar irradiation with low incident levels of mid-infrared energy which contributes to the prevention of dementia associated with underlying diabetes mellitus.Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine.Plasma metabolomic profiling of patients with diabetes-associated cognitive decline.Associations between Retinal Markers of Microvascular Disease and Cognitive Impairment in Newly Diagnosed Type 2 Diabetes Mellitus: A Case Control StudyAn increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control studyNeural stem cells in the diabetic brainAssociations between Markers of Glucose and Insulin Function and Cognitive Function in Healthy African American Elders.The endothelium in diabetes: its role in insulin access and diabetic complicationsBiomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of NutraceuticalsIntranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.From gut dysbiosis to altered brain function and mental illness: mechanisms and pathwaysThe Association of Type 2 Diabetes Mellitus with Cerebral Gray Matter Volume Is Independent of Retinal Vascular Architecture and Retinopathy.The Facilitative Effect of Transcranial Direct Current Stimulation on Visuospatial Working Memory in Patients with Diabetic Polyneuropathy: A Pre-post Sham-Controlled StudyBrain atrophy in type 2 diabetes: regional distribution and influence on cognitionSmall vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia.Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy.The meaning of burden of care in a faith-based community: the case of ultra-Orthodox Jews (UOJ).Sodium thiosulphate attenuates brain inflammation induced by systemic lipopolysaccharide administration in C57BL/6J mice.Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia.Influence of pneumonia complications on the prognosis of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and vascular dementia.Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I.Gender Differences in Trajectories of Physical Activity Among Older Americans With Diabetes.
P2860
Q26783344-CD5CFE78-4FAD-4417-94F8-82DAC55C6CABQ26799893-68C3BF94-8CD8-4835-B719-12BD19EBD036Q26825253-B511D8C5-3083-45FE-A4EC-826443735EC6Q27301438-3FF89FC9-0443-4278-A030-B5018FEE6941Q28083039-55E9A875-DE4F-4A8E-82A1-3581814DFB7DQ33558758-A772D79E-2093-442E-9324-BE36F4043A79Q33632895-A4685795-7962-4A6C-9ED2-BBDE61ACA3DDQ33780337-722E833D-9698-4C8B-8F27-CB32A4C2A09FQ33906496-834D1714-739B-459A-8709-ACD87493D509Q34278350-9081136A-F6B5-4A44-8B7D-6FF7870EAC4AQ34319623-AF6A6DD8-D200-4F85-85B6-F5B68AA2179AQ34760782-21AF39D7-E762-476B-A40B-C369A7EF9EA5Q35013166-362C13BB-4C5C-426E-BB7E-3D37ABC9F46DQ35123008-10BD1128-EFCC-4234-B67D-9C4058A968DFQ35216040-FED726EA-2B2D-4A6A-B9AC-18E67C90165DQ35558910-D6C04035-491D-431A-81A2-D432436D01BFQ35594507-6780E611-66DF-4FA0-9511-10DDAA164606Q35606865-B0686B76-3A85-4A2A-A016-F3010F87268DQ35895087-0179559B-4A3C-4B93-9B36-8E4D4BAC95F8Q36153827-B37CB191-6E67-4EC0-BD5D-5DBE5EC19FD1Q36421280-A89390B5-394C-4EBD-99C4-1CC65EF1A117Q36479052-A00B86A3-99C6-40F5-B428-D967BB7FA3D4Q36672866-F592338F-CE11-4370-B7BC-5095822AEEBDQ36754193-ACEE7246-A20F-4BC6-9364-848D81B62E2AQ36781712-5D184EBC-E425-4D6A-A4EB-E805D1F2C017Q36883430-FC42487A-7538-43FD-90AB-A34EF9150B4AQ36932850-E9006270-0119-43B0-B37C-0BCFE939262EQ36980446-79A89E3D-F8E9-430E-B821-4EADED5C5E7AQ37289937-11089313-A74A-47C1-A6EA-911283C5458DQ37331270-B514E90C-0E77-449C-926A-006BD6829949Q38150763-9A686313-AAF2-4CA1-B1AD-A09C2FD2507EQ38234927-4B79F23D-D580-42A8-BD9D-B21047A109F2Q38673914-2ABF6E1C-4B54-4584-B563-CEC693E0A013Q38906901-817ECEDB-9BC3-4B3E-9E72-8CC3031FED43Q39825119-16238B70-14C1-4243-9793-82A3D55A9BE5Q40205263-4E166E9C-C920-4C00-9B9D-F889716746B7Q40260512-58147625-1FEE-4F77-8D16-07D99280D316Q40383156-5064D388-F86A-4C74-ABD5-D382193D0FF2Q40549777-E64A2C90-F07C-4F88-A61D-5E38E86B3825Q40723026-64DFB1F0-DFA7-4D85-BBA6-1648B2AE0B9A
P2860
An update on type 2 diabetes, vascular dementia and Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An update on type 2 diabetes, vascular dementia and Alzheimer's disease.
@en
type
label
An update on type 2 diabetes, vascular dementia and Alzheimer's disease.
@en
prefLabel
An update on type 2 diabetes, vascular dementia and Alzheimer's disease.
@en
P2093
P921
P1476
An update on type 2 diabetes, vascular dementia and Alzheimer's disease.
@en
P2093
G J Biessels
L G Exalto
L J Kappele
R A Whitmer
P304
P356
10.1016/J.EXGER.2012.07.014
P577
2012-08-03T00:00:00Z